These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31449559)

  • 21. Estimating the Cost of Point-of-Care Early Infant Diagnosis in a Program Setting: A Case Study Using Abbott m-PIMA and Cepheid GeneXpert IV in Zimbabwe.
    Mukherjee S; Cohn J; Ciaranello AL; Sacks E; Adetunji O; Chadambuka A; Mafaune H; Makayi M; McCann N; Turunga E
    J Acquir Immune Defic Syndr; 2020 Jul; 84 Suppl 1():S63-S69. PubMed ID: 32520917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near point-of-care HIV viral load testing: Cascade after high viral load in suburban Yangon, Myanmar.
    Tun NN; Smithuis F; Tun NL; Min M; Hlaing MMM; Olmen JV; Lynen L; Gils T
    PLoS One; 2023; 18(4):e0272673. PubMed ID: 37053171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.
    McCann NC; Cohn J; Flanagan C; Sacks E; Mukherjee S; Walensky RP; Adetunji O; Maeka KK; Panella C; Chadambuka A; Mafaune H; Odhiambo C; Freedberg KA; Ciaranello AL
    J Acquir Immune Defic Syndr; 2020 Jul; 84 Suppl 1(1):S12-S21. PubMed ID: 32520910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Near-point-of-care viral load testing during pregnancy and viremia at delivery.
    Joseph J; Boeke CE; Makadzange EE; Sithole K; Maparo T; Mangwendeza PM; Peter T; Sacks JA; Simbi R; Khan S; Mushavi A
    AIDS; 2022 Apr; 36(5):711-719. PubMed ID: 35025819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and impact of near-point-of-care integrated tuberculosis/HIV testing in Malawi and Zimbabwe.
    Wang M; Boeke CE; Rioja MR; Maparo T; Banda C; Chavula C; Gunda A; Isaac J; Mangwiro A; Mangwendeza PM; Mtaula J; Mwase C; Doi N; Peter T; Kandulu J; Simbi R; Khan S; Sacks JA
    AIDS; 2021 Dec; 35(15):2531-2537. PubMed ID: 34310372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 viral load testing among the people living with HIV attending ART centers in India.
    Kamble S; Shidhaye P; Mukherjee A; Tak M; Bembalkar S; Aggarwal S; Deb A; Kapoor N; Verma V; Das C; Kulkarni S; Ghate M; Godbole S
    PLoS One; 2023; 18(5):e0285942. PubMed ID: 37200292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The feasibility and acceptability of integrating hepatitis C and HIV diagnostic testing on centralized molecular laboratory platforms in Myanmar.
    Naing TS; Yee WW; Aung HT; Oo KY; Tint KS; Boeke CE; Chan Y; Witschi M; Nwe N; Markby J; Shilton S; Aung KS; Oo HN; Aye MM; Htay TT
    PLoS One; 2023; 18(5):e0282585. PubMed ID: 37195968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries.
    Bianchi F; Cohn J; Sacks E; Bailey R; Lemaire JF; Machekano R;
    Lancet HIV; 2019 Jun; 6(6):e373-e381. PubMed ID: 30987937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes.
    Bardon AR; Dorward J; Sookrajh Y; Sayed F; Quame-Amaglo J; Pillay C; Feutz E; Ngobese H; Simoni JM; Sharma M; Cressey TR; Gandhi M; Lessells R; Moodley P; Naicker N; Naidoo K; Thomas K; Celum C; Abdool Karim S; Garrett N; Drain PK
    BMJ Open; 2021 Oct; 11(10):e050116. PubMed ID: 34610939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.
    Ndlovu Z; Fajardo E; Mbofana E; Maparo T; Garone D; Metcalf C; Bygrave H; Kao K; Zinyowera S
    PLoS One; 2018; 13(3):e0193577. PubMed ID: 29499042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness of POC Coagulation Testing Using Multiple Electrode Aggregometry.
    Straub N; Bauer E; Agarwal S; Meybohm P; Zacharowski K; Hanke AA; Weber CF
    Clin Lab; 2016; 62(6):1167-78. PubMed ID: 27468580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care.
    Kip MMA; Koffijberg H; Moesker MJ; IJzerman MJ; Kusters R
    BMC Cardiovasc Disord; 2017 Aug; 17(1):213. PubMed ID: 28768475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point-of-Care Virologic Testing to Improve Outcomes of HIV-Infected Children in Zambia: A Clinical Trial Protocol.
    Chibwesha CJ; Ford CE; Mollan KR; Stringer JS
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S197-201. PubMed ID: 27355509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Testing Can Be Done Anywhere": A Qualitative Assessment of Targeted Community-Based Point-of-Care Early Infant Diagnosis of HIV in Lusaka, Zambia.
    Tembo T; Dale H; Muttau N; Itoh M; Williamson D; Mwamba C; Manasyan A; Beard RS; Cox MH; Herce ME
    Glob Health Sci Pract; 2022 Jun; 10(3):. PubMed ID: 36332072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-effectiveness of upfront point-of-care testing in the emergency department: a secondary analysis of a randomised, controlled trial.
    Goldstein LN; Wells M; Vincent-Lambert C
    Scand J Trauma Resusc Emerg Med; 2019 Dec; 27(1):110. PubMed ID: 31829227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis.
    Trickey A; Fajardo E; Alemu D; Artenie AA; Easterbrook P
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):253-270. PubMed ID: 36706775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of point-of-care management on the transmission of anogenital gonococcal infections among men who have sex with men in Amsterdam: a mathematical modelling and cost-effectiveness study.
    Bartelsman M; Vaughan K; van Rooijen MS; de Vries HJC; Xiridou M
    Sex Transm Infect; 2018 May; 94(3):174-179. PubMed ID: 28942419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic and public health impact of decentralized HIV viral load testing: A modelling study in Kenya.
    de Necker M; de Beer JC; Stander MP; Connell CD; Mwai D
    PLoS One; 2019; 14(2):e0212972. PubMed ID: 30811510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation and operational feasibility of SAMBA I HIV-1 semi-quantitative viral load testing at the point-of-care in rural settings in Malawi and Uganda.
    Gueguen M; Nicholas S; Poulet E; Schramm B; Szumilin E; Wolters L; Wapling J; Ajule E; Rakesh A; Mwenda R; Kiyaga C; Balkan S
    Trop Med Int Health; 2021 Feb; 26(2):184-194. PubMed ID: 33159822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point-of-care CD4+ technology implementation in Free State, South Africa, was associated with improved patient health outcomes.
    Van Turha L; Maharaj K; Rose A; Boeke C; Peter TF; Vojnov L; Quevedo J; Tsibolane Y
    S Afr Med J; 2020 Jan; 110(2):126-131. PubMed ID: 32657683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.